ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years
Laura L. Dover
Matched on ORCID iD 0000-0002-2749-4712; OpenAlex author ID A5108766999. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 1
2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 2 papers
Papers 3
- PROshot: Neoadjuvant Radiation for Pancreatic Cancer, Radiation Alone for Oligometastatic Renal Cell Carcinoma, De-escalated Head and Neck Radiation, and Immun… First author DOI 10.1016/j.prro.2025.10.001↗
- PROshot: Ablative Radiation for Renal Cell Carcinoma, Adjuvant Radiation for Pancreatic Cancer, Consolidative Thoracic Radiation, and Oligometastatic Disease. First author DOI 10.1016/j.prro.2026.08.007↗
- PROshot: Locoregional Therapy for Metastatic Breast Cancer, Abiraterone in Very High-Risk Prostate Cancer, Neoadjuvant Chemoradiation for Resectable Pancreatic… First author DOI 10.1016/j.prro.2022.02.007↗
Closest collaborators
The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Caleb R. Dulaney · 3 shared papers, 2022–2026 · strength 1.59
- Paper PROshot: Neoadjuvant Radiation for Pancreatic Cancer, Radiation Alone for Oligometastatic Renal Cell Carcinoma, De-esca… DOI 10.1016/j.prro.2025.10.001↗
- Paper PROshot: Ablative Radiation for Renal Cell Carcinoma, Adjuvant Radiation for Pancreatic Cancer, Consolidative Thoracic … DOI 10.1016/j.prro.2026.08.007↗
- Paper PROshot: Locoregional Therapy for Metastatic Breast Cancer, Abiraterone in Very High-Risk Prostate Cancer, Neoadjuvant … DOI 10.1016/j.prro.2022.02.007↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.